Differential expression of specific microRNA and their targets in acute myeloid leukemia

American Journal of Hematology

Volumn 85, Issue 5, 2010, Pages 331-339

  Cammarata, Giuseppe ^a,b   Augugliaro, Luigi ^c   Salemi, Domenico ^a   Agueli, Cecilia ^a   La Rosa, Maria ^a   Dagnino, Lea ^a   Civiletto, Gabriele ^a   Messana, Francesca ^a   Marfia, Anna ^a   Bica, Maria Grazia ^a   Cascio, Lucia ^a   Floridia, Pietro Michele ^d   Mineo, Angelo M ^c   Russo, Mario ^d   Fabbiano, Francesco ^a   Santoro, Alessandra ^a  

^a Ospedali Riuniti Villa Sofia Cervello   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Divisione di Ematologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; LEUKEMOGENESIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CORE BINDING FACTORS; DOWN-REGULATION; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE PRECURSOR CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; YOUNG ADULT;

EID: 77951540421     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21667     Document Type: Article

References (56)

1. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer. 2007;7:233-245. (Pubitemid 46480968)
2. Mrózek K, Marcucci G, Paschka P, et al. Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia. Curr Opin Oncol 2008;20:711-718.
3. Haferlach T, Bacher U, Haferlach C, et al. Insight into the molecular pathogenesis of myeloid malignancies. Curr Opin Hematol 2007;14:90-97. (Pubitemid 46175092)
4. Paschka P. Core binding factor acute myeloid leukemia. Semin Oncol 2008;35:410-417.
5. Falini B, Nicoletti I, Martelli MF, et al. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc1 AML): Biologic and clinical features. Blood 2007;109:874-885. (Pubitemid 46220630)
6. Renneville A, Roumier C, Biggio V, et al. Cooperating gene mutations in acute myeloid leukemia: A review of the literature. Leukemia 2008;22:915-931. (Pubitemid 351709343)
7. Cheng K, Sportoletti P, Ito K, et al. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model. Blood, Aug 2009; doi: 10.1182/blood-2009-03-208587.
8. Isken F, Steffen B, Merk S, et al. Identification of acute myeloid leukaemia associated microRNA expression patterns. Br J Haematol 2008;140:153-161. (Pubitemid 350265050)
9. Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukaemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008;105:3945-3950. (Pubitemid 351723504)
10. Garzon R, Volinia S, Liu C, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008;11:3183-3189.
11. Marcucci G, Radmacher MD, Maharry K, et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008;358:1919-1928. (Pubitemid 351620112)
12. Jongen-Lavrencic M, Sun SM, Dijkstra MK, et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukaemia. Blood 2008;15:5078-5085.
13. Li Z, Lu J, Sun M, et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008;105:15535-15540.
14. Dixon-McIver A, East P, Mein CA, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 2008; 14: 2141. (Pubitemid 352025167)
15. Mi S, Lu J, Sun M, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukaemia from acute myeloid leukaemia. Proc Natl Acad Sci USA 2007;104:19971-19976.
16. Bartel D. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
17. Fazi F, Rosa A, Fatica A, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005;123:819-831.
18. Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006;103:5078-5083.
19. Debernardi S, Skoulasis S, Molloy G, et al. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007;21:912-916. (Pubitemid 46672066)
20. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc Natl Acad Sci USA 2002;99:15524-15529. (Pubitemid 35403967)
21. Cimmino A, Calin GA, Fabbri M, et al. miR15 and miR16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-13949. (Pubitemid 41377683)
22. Mitelman F. An International System for Human Cytogenetic Nomenclature (ISCN), 2nd ed. Basel: S. Karger; 1995.
23. Gabert J, Beillard E, van der Velden VHJ, et al. Standardization and quality control studies of 'real-time' quantitative reversetranscriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe against cancer program. Leukemia 2003;17: 2318-2357.
24. Meshinchi S, Woods WG, Stirewalt DL, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001;97:89-94. (Pubitemid 32061246)
25. Falini B, Mecucci C, Tiacci E, et al. GIMEMA acute leukemia working partycytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005;352:254-266.
26. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:36.
27. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838. (Pubitemid 40839735)
28. Georgiantas RW, Hildreth R, Morisot S, et al. CD341 hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007;104:27-50-2755.
29. le Sage C, Nagel R, Egan DA, et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007;26:3699-3708. (Pubitemid 47236875)
30. Marcucci G, Mròzek K, Radmacher MD, et al. MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias. Best Pract Res Clin Haematol 2009;22:239-248.
31. Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profile in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198. (Pubitemid 43357945)
32. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-647. (Pubitemid 40343076)
33. Slack F. let-7 microRNA reduces tumor growth Cell Cycle 2009;8:1823.
34. Laios A, O'Toole S, Flavin R, et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008;28:35-39. (Pubitemid 351699620)
35. Navarro A, Diaz T, Martinez A, et al. Regulation of JAK2 by miR-135a: Prognostic impact in classical Hodgkin. Blood 2009;114:2945-2951.
36. Slezak S, Jin P, Caruccio L, et al. Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: Down-regulationof micro RNA-1 and 2133a. J Trans Med 2009;7:39-43.
37. Wong TS, Liu XB, Chung-Wai HA, et al. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer 2008;123:251-257.
38. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005;102:18081-18086. (Pubitemid 41798505)
39. Cairoli R, Grillo G, Beghini A, et al. C-Kit point mutations in core binding factor leukemias: Correlation with white blood cell count and the white blood cell index. Leukemia 2003;17:471-472. (Pubitemid 36266930)
40. Paschka P, Marcucci G, Ruppert AS, et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B Study. J Clin Oncol 2006;24:3904-3911. (Pubitemid 46630738)
41. Pekarsky Y, Santanam U, Cimmino A, et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006;66:11590-11593. (Pubitemid 46094168)
42. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007;104:15805-15810. (Pubitemid 350035380)
43. Popovic R, Riesbeck LE, Velu CS, et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009;113:3314-3322.
44. Mansfiel JH, Harfe BD, Nissen R, et al. MicroRNA-responsive "sensor" transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 2004;36:1079-1108.
45. Alcalay M, Tiacci E, Bergomas R, et al; and for the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Acute Leukemia Working Party. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc1 AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005;106:899-902.
46. Andreeff M, Ruvolo V, Gadgil S, et al. HOX expression patterns identify a common signature for favorable AML. Leukemia 2008;22:2041-2047.
47. Zhang X, Lian Z, Padden C, et al. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 2009;113:2526-2534.
48. Thompson A, Quinn MF, Grimwade D, et al. Global down-regulation of HOX gene expression in PML-RARalpha 1 acute promyelocytic leukemia identified by small-array real-time PCR. Blood 2003;101:1558-1565. (Pubitemid 36182534)
49. Rice KL, Licht JD. HOX deregulation in acute myeloid leukemia. J Clin Invest 2007;117:865-868. (Pubitemid 46556740)
50. Fontana L, Pelesi E, Greco P, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007;9:775-787. (Pubitemid 47019464)
51. Ben-Ami O, Pencovich N, Lotem J, et al. A regulatory interplay between miR-27a and Runx1during megakaryopoiesis. PNAS 2009; 106:238-243.
52. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008;205:585-594.
53. Rosenbauer F, Tenen GD. Transcription factors in myeloid development: Balancing differentiation with transformation. Nat Rev 2007;7:105-117. (Pubitemid 46174858)
54. Mueller BU, Pabst T, Osato M, et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 2002;100:998-1007. (Pubitemid 34832629)
55. Vegesna V, Takeuchi S, Hofmann WK, et al. C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: Mutational analysis in 381 samples of hematopoietic and solid malignancies. Leuk Res 2002;26:451-457.
56. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008;105:13556-13561.